Apoptotic resistance exhibited by dexamethasone-resistant murine 7TD1 cells is controlled independently of interleukin-6 triggered signaling

Apoptosis

Volumn 13, Issue 11, 2008, Pages 1394-1400

  Gangavarapu, Kalyan J ^a   Olbertz, Joy L ^a   Bhushan, Alok ^a   Lai, James C K ^a   Daniels, Christopher K ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell signaling; Dexamethasone resistance; Interleukin 6; Multiple myeloma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DEXAMETHASONE; ETOPOSIDE; INTERLEUKIN 6; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 INHIBITOR PEPTIDE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL PROLIFERATION; CONTROLLED STUDY; DIMERIZATION; DRUG SENSITIVITY; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; B-LYMPHOCYTES; CELL LINE, TUMOR; DEXAMETHASONE; ENZYME INHIBITORS; HUMANS; HYBRIDOMAS; INTERLEUKIN-6; MICE; MULTIPLE MYELOMA; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

MURINAE;

EID: 53849121921     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-008-0265-y     Document Type: Article

References (35)

1. B Klein XG Zhang ZH Lu R Bataille 1995 Interleukin-6 in human multiple myeloma Blood 85 863 872
2. HR De Raeve K Vanderkerken 2005 The role of the bone marrow microenvironment in multiple myeloma Histol Histopathol 20 1227 1250
3. K Gado G Domjan H Hegyesi A Falus 2000 Role of interleukin-6 in the pathogenesis of multiple myeloma Cell Biol Int 4 195 209 10.1006/cbir.2000.0497
4. M Hallek L Bergsagel KC Anderson 1998 Multiple myeloma: increasing evidence for a multistep transformation process Blood 91 3 21
5. M Chatterjee D Honemann S Lentzsch K Bommert C Sers P Herrmann 2002 In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway Blood 100 3311 3318 10.1182/blood-2002-01-0102
6. M Frassanito A Cusmai G Iodice F Dammacco 2001 Autocrine inteleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis Blood 97 483 489 10.1182/blood.V97.2.483
7. D Chauhan P Pandey T Hideshima 2000 SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells J Biol Chem 275 27845 27850
8. L Song Y Li YX Sun M Yu BF Shen 2002 IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1 Ai Zheng 21 113 116
9. J Hardin S MacLeod I Grigorieva 1994 Interleukin-6 prevents dexamethasone-induced myeloma cell death Blood 84 3063 3070
10. S Greenstein NL Krett Y Kurosawa C Ma D Chauhan T Hideshima 2003 Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells Exp Hematol 31 271 282 10.1016/S0301-472X(03)00023-7
11. B Bruno L Giaccone M Rotta KC Anderson M Boccadoro 2005 Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside Leukemia 19 1729 1738 10.1038/sj.leu.2403905
12. B Bruno M Rotta L Giaccone M Massaia A Bertola A Palumbo 2004 New drugs for treatment of multiple myeloma Lancet Oncol 5 430 442 10.1016/S1470-2045(04) 01511-6
13. T Hideshima D Chauhan P Richardson KC Anderson 2005 Identification and validation of novel therapeutic targets for multiple myeloma J Clin Oncol 23 6345 6350 10.1200/JCO.2005.05.024
14. M Portier XG Zhang E Ursule D Lees M Jourdan R Bataille 1993 Cytokine gene expression in human multiple myeloma Br J Haematol 85 514 520
15. M Kawano T Hirano T Matsuda 1998 Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas Nature 332 83 85 10.1038/332083a0
16. + mature myeloma cells Int J Hematol 63 215 226 10.1016/0925-5710(96)00439-2
17. T Taga Y Kawanishi RR Hardy T Hirano T Kishimoto 1987 Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution and regulation of their expression J Exp Med 166 967 981 10.1084/jem.166.4.967
18. J Bauer TM Bauer T Kalb T Taga G Lengyel T Hirano 1989 Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes J Exp Med 170 1537 1549 10.1084/jem.170.5.1537
19. J Bauer G Lengyel TM Bauer G Acs W Gerok 1989 Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes FEBS Lett 249 27 30 10.1016/0014-5793(89)80008-0
20. M Saito K Yoshida M Hibi T Taga T Kishimoto 1992 Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo J Immunol 148 4066 4071
21. M Hibi M Murakami M Saito T Hirano T Taga T Kishimoto 1990 Molecular cloning and expression of an IL-6 signal transducer, gp130 Cell 63 1149 1157 10.1016/0092-8674(90)90411-7
22. K Yamasaki T Taga Y Hirata H Yawata Y Kawanishi B Seed 1988 Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor Science 241 825 828 10.1126/science.3136546
23. MJ Boulanger DC Chow EE Brevnova KC Garcia 2003 Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex Science 300 2101 2104 10.1126/science.1083901
24. PC Heinrich I Behrmann S Haan HM Hermanns G Muller-Newen F Schaper 2003 Principles of interleukin (IL)-6-type cytokine signaling and its regulation J Biochem 374 1 20 10.1042/BJ20030407
25. A Ogata D Chauhan G Teoh SP Treon M Urashima RL Schlossman 1997 IL6 triggers cell growth via Ras-dependent MAPK cascade J Immunol 159 2212 2221
26. S Lentzsch M Chatterjee M Gries K Bommert H Gollasch B Dorken 2004 PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells Leukemia 18 1883 1890 10.1038/sj.leu.2403486
27. Y Tu A Gardner A Lichtenstein 2000 The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses Cancer Res 60 6763 6770
28. UM Wegenka C Lutticken J Buschmann J Yuan F Lottspeich W Muller-Esterl 1994 The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family Mol Cell Biol 14 3186 3196
29. B Irvin C Hanson L Smith CK Daniels 2001 Cyclic Amp-IL6-sigaling cross talk: comodulation of proliferation and apoptosis in the 7TD1 B cell hybridoma Exp Cell Res 265 73 79 10.1006/excr.2001.5157
30. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 10.1016/0022-1759(83)90303-4
31. J Turkson D Ryan JS Kim Y Zhang Z Chen E Haura 2001 Phosphoryltyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation and cell transformation J Biol Chem 276 45443 45455 10.1074/jbc.M107527200
32. R Catlett-Falcone TH Landowski MM Oshiro J Turkson A Levitzki R Savino 1999 Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells Immunity 10 105 115 10.1016/S1074-7613(00)80011-4
33. J Vos M Jourdan K Tarte C Jasmin B Klein 2000 JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells Br J Haematol 109 823 828 10.1046/j.1365-2141.2000.02127.x
34. J Zhang Y Li B Shen 2003 PI3K/AKT pathway contributes to IL-6-dependent growth of 7TD1 cells Cancer Cell Int 3 1 4 10.1186/1475-2867-3-1
35. DR Hodge W Xiao HW Li D Li WL Farrar 2004 Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells Cancer Biol Ther 3 188 194